Publicly traded company BioSig has announced a merger with Streamex, aiming to raise $1.1 billion to advance RWA tokenization development

BlockBeats News, July 8th, BioSig Technologies, a U.S. Nasdaq-listed medical device technology company, announced that it has merged with another Nasdaq-listed company, Streamex Exchange Corporation, and has also signed a financing agreement of up to $1.1 billion to advance its RWA tokenization business, aiming to bring the $142 trillion commodity market onto the blockchain with a focus on gold tokenization.

The company will issue $100 million worth of senior secured convertible bonds and a $1 billion equity line of credit, with the transaction being co-lead by Cantor Fitzgerald, the asset custodian of Tether.

Streamex is a wholly-owned subsidiary of BioSig Technologies, Inc., and is a real-world asset (RWA) tokenization company focusing on the commodity sector. Streamex aims to blockchainize the commodity market and has developed the primary issuance and trading infrastructure that will fundamentally transform commodity finance.